Sermorelin 10MG
Sermorelin is a 29-amino acid synthetic analog of the N-terminal fragment of growth hormone releasing hormone (GHRH). For Sermorelin (GRF 1-29), each vial is labeled 10MG, molecular formula C149H246N44O42S, molecular weight 3,357.93 Da, CAS 86168-78-7.
Published laboratory work with Sermorelin (GRF 1-29) has examined GHRH receptor signaling, pulsatile GH release studies, pituitary somatotroph pathway models. Each lot is manufactured under sterile conditions, lyophilized in single-use research vials, and labeled with its production lot for traceability.
Supplied for in-vitro laboratory research use only. Not for human or veterinary consumption, administration, diagnostic or therapeutic use.
Synthetic 29-amino acid GHRH analog (GRF 1-29) researched for pituitary-mediated growth hormone release and endocrine axis studies.
Background reading on this compound in the ENOS Lab Notes: CJC-1295 and Ipamorelin: Receptor Research Review.
Background reading: the Sermorelin compound reference, how to read a certificate of analysis, why purity and identity are separate tests and storage and handling guidance.
Comparing GHRH analogs? See Tesamorelin 10MG, the full length 44 amino acid GHRH analog.
- Ships from Arizona
- Free shipping through Nov 14
- Zelle, Venmo, Cash App, USDT
These products are sold strictly for in-vitro laboratory research and are not intended for human consumption, diagnosis, treatment, or any therapeutic use. Purchaser must be 18 years of age or older and confirms they are a qualified researcher.
Compound identity
Listed on the storefront as Sermorelin. The compound information for this research vial is below.
- Compound name
- Sermorelin (GRF 1-29)
- Also known as
- GRF 1-29, GHRH (1-29) NH2, Sermorelin acetate
- Molecular formula
- C149H246N44O42S
- Molecular weight
- 3,357.93 Da
- CAS number
- 86168-78-7
- Vial size
- 10MG
Product Information
Research DatasheetProduct Overview
Sermorelin is a 29-amino acid synthetic analog of the N-terminal fragment of growth hormone releasing hormone (GHRH). It is studied as a GHRH receptor agonist for pituitary-mediated, pulsatile growth hormone release in laboratory models. Lyophilized under sterile conditions. For laboratory research use only. Not for human or veterinary use.
Molecular Profile
Research Applications
- ◆GHRH receptor signaling research
- ◆Pulsatile GH release studies
- ◆Pituitary somatotroph pathway models
- ◆Comparative secretagogue pharmacology
- ◆Peptide stability and handling research
Quality Standards
Lab documentation: available on request, info@enosusa.com
For in-vitro research use only. Not for human consumption, diagnosis, or treatment.
Synthetic 29-amino acid GHRH analog (GRF 1-29) researched for pituitary-mediated growth hormone release and endocrine axis studies. All ENOS research vials are lyophilized, sealed under sterile conditions, and shipped with cold-chain packaging where appropriate.
- ◆GHRH pathway research
- ◆Pulsatile GH studies
- ◆GHRH receptor agonist
You may also like
HGH · 10 × 10IU Kit
Recombinant human growth hormone (rhGH) research kit, 10 vials of 10IU.
Tesamorelin · 10MG
GHRH analog research peptide studied in pulsatile growth hormone release models.
CJC-1295 + IPA Blend · 10MG
CJC-1295 (no DAC) and Ipamorelin in one vial for GHRH and ghrelin receptor research.
